Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases

Clinical and Therapeutic Evaluation of Meloxicam in Mexican Patients With Rheumatic Diseases

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02184065

Enrollment

22639

Registered

2014-07-09

Start date

2004-01-31

Completion date

Unknown

Last updated

2014-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis, Rheumatoid

Brief summary

Observational study to evaluate the efficacy and safety of meloxicam (Mobicox®) in Mexican population with rheumatic diseases

Interventions

DRUGMeloxicam

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

12 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age of 12 or older and rheumatologic disease

Exclusion criteria

* Hypersensitivity to meloxicam * Hypersensitivity to other Non-steroidal anti-inflammatory drugs (NSAIDS) * History of asthma, angioedema or urticaria secondary to NSAIDS * Pregnancy or lactation * Recent or current history of peptic ulcer disease, severe renal failure and severe hepatic failure

Design outcomes

Primary

Measure	Time frame
Intensity of symptoms at rest evaluated with a 4-point scale	30 and 90 days
Intensity of symptoms during movement evaluated with a 4-point scale	30 and 90 days
Medical global evaluation on a 4-point scale	30 and 90 days

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026